Takeda Pharmaceutical
TAK
#451
Rank
โ‚ฌ48.24 B
Marketcap
15,11ย โ‚ฌ
Share price
1.06%
Change (1 day)
22.82%
Change (1 year)

Operating Margin for Takeda Pharmaceutical (TAK)

Operating Margin as of July 2026 (TTM): 0.92%

According to Takeda Pharmaceutical's latest financial reports and stock price the company's current Operating Margin is 0.92%. At the end of 2026 the company had an Operating Margin of -3.16%.

Operating Margin history for Takeda Pharmaceutical from 2009 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
2026-3.16%-182.68%
20253.82%208.65%
20241.24%-86.71%
20239.31%9.86%
20228.48%-25.98%
202111.45%-720.42%
2020-1.85%-130.34%
20196.08%-50.4%
201812.27%48.23%
20178.28%24.09%
20166.67%-181.53%
2015-8.18%-187.12%
20149.39%9.87%
20138.55%-48.92%
201216.73%-36.08%
201126.18%-7.71%
201028.37%9.49%
200925.91%-38.25%
200841.96%-12.43%
200747.92%12.14%
200642.73%8.78%
200539.28%-4.35%
200441.07%-0.54%
200341.29%11.12%
200237.15%36.07%
200127.30%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58% 3,658.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
27.89% 2,931.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
12.01% 1,205.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
24.41% 2,553.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
13.21% 1,335.87%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
32.40% 3,421.74%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
22.66% 2,363.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-30.69%-3,435.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
17.63% 1,816.30%๐Ÿ‡ฎ๐Ÿ‡ณ India

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.